Unknown

Dataset Information

0

Frontoparietal paired associative stimulation versus single-site stimulation for generalized anxiety disorder: a pilot rTMS study.


ABSTRACT:

Background

At present, the use of repetitive transcranial magnetic stimulation (rTMS) for generalized anxiety disorder (GAD) is limited to single-site interventions. We investigated whether dual-site frontoparietal stimulation delivered using cortical-cortical paired associative stimulation (ccPAS) had stronger clinical efficacy than single-site stimulation in patients with GAD.

Methods

We randomized 50 patients with GAD to 1 Hz rTMS (10 sessions) using 1 of the following protocols: single-site stimulation over the right dorsolateral prefrontal cortex (dlPFC; 1500 pulses per session); single-site stimulation over the right posterior parietal cortex (PPC; 1500 pulses per session); repetitive dual-site ccPAS (rds-ccPAS) over the right dlPFC and right PPC with 1500 pulses per session (rd-ccPAS-1500); or rds-ccPAS over the right dlPFC and right PPC with 750 pulses per session (rd-ccPAS-750). Both rds-ccPAS treatments used a between-site interval of 100 ms.

Results

Clinical scores for anxiety, depression and insomnia were reduced in all 4 groups after treatment. We found greater improvements in anxiety symptoms in the rds-ccPAS-1500 group compared to the rds-ccPAS-750 and single-site groups. We found greater improvements in depression symptoms and insomnia in the rds-PAS-1500 group compared to the single-site groups. The rds-ccPAS-1500 group also showed significant or trend-level improvements in anxiety symptoms and insomnia at 10-day and 1-month followup. More patients responded to treatment with rds-ccPAS-1500 than with single-site stimulation. The between-group differences in response rates persisted to the 3-month follow-up. Treatment using rds-ccPAS with a between-site interval of 100 ms induced a more significant improvement than the between-site interval of 50 ms we evaluated in a previous study.

Limitations

These results need to be replicated in a larger sample using sham control and equal-pulse single-site stimulation.

Conclusion

Frontoparietal rds-ccPAS may be a better treatment option for GAD.

SUBMITTER: Wang L 

PROVIDER: S-EPMC9259432 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6664322 | biostudies-literature
| S-EPMC4748309 | biostudies-literature
2014-12-01 | GSE61672 | GEO
| S-EPMC7918620 | biostudies-literature
| S-EPMC7729006 | biostudies-literature
| S-EPMC7541941 | biostudies-literature
| S-EPMC5610384 | biostudies-literature
| S-EPMC6676880 | biostudies-literature
| S-EPMC6885044 | biostudies-literature
| S-EPMC6869416 | biostudies-literature